BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35393655)

  • 1. The prevalence of nonmelanoma skin cancer in a population of patients with oculocutaneous albinism in Haiti.
    Hassan S; Louis SJ; Fethiere M; Dure D; Rosen J; Morrison BW
    Int J Dermatol; 2022 Jul; 61(7):867-871. PubMed ID: 35393655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatological and Epidemiological Profiles of Patients with Albinism in São Paulo, Brazil, between 2010 and 2017: A Cross-Sectional Study.
    Marçon CR; Moraes JC; de Olivas Ferreira MAM; Oliari CB
    Dermatology; 2020; 236(3):219-227. PubMed ID: 31461704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing melanoma in the setting of oculocutaneous albinism: an analysis of the literature.
    Ravichandran S; Funchain P; Arbesman J
    Arch Dermatol Res; 2023 Oct; 315(8):2413-2417. PubMed ID: 35849167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case for the inclusion of oculocutaneous albinism as a skin-related Neglected Tropical Disease].
    Aquaron R; Lund P; Baker C
    Med Trop Sante Int; 2023 Dec; 3(4):. PubMed ID: 38390024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of premalignant and malignant skin lesions in oculocutaneous albinism patients.
    Ramos AN; Ramos JGR; Fernandes JD
    Rev Assoc Med Bras (1992); 2021 Jan; 67(1):77-82. PubMed ID: 34161467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of oculocutaneous albinism in Zimbabwe.
    Lund PM
    J Med Genet; 1996 Aug; 33(8):641-4. PubMed ID: 8863154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
    Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculocutaneous albinism.
    Grønskov K; Ek J; Brondum-Nielsen K
    Orphanet J Rare Dis; 2007 Nov; 2():43. PubMed ID: 17980020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining a Worldwide Prevalence of Oculocutaneous Albinism: A Systematic Review.
    Kromberg JGR; Flynn KA; Kerr RA
    Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):14. PubMed ID: 37440261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics.
    Simeonov DR; Wang X; Wang C; Sergeev Y; Dolinska M; Bower M; Fischer R; Winer D; Dubrovsky G; Balog JZ; Huizing M; Hart R; Zein WM; Gahl WA; Brooks BP; Adams DR
    Hum Mutat; 2013 Jun; 34(6):827-35. PubMed ID: 23504663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Might the refractive state in oculocutaneous albino patients be a clue for distinguishing between tyrosinase-positive and tyrosinase-negative forms of oculocutaneous albinism?
    Käsmann B; Ruprecht KW
    Ger J Ophthalmol; 1996 Nov; 5(6):422-7. PubMed ID: 9479530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetics of oculocutaneous albinism].
    Zühlke C; Stell A; Käsmann-Kellner B
    Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous-cell carcinoma in situ in a patient with oculocutaneous albinism.
    Berger E; Hunt R; Tzu J; Patel R; Sanchez M
    Dermatol Online J; 2011 Oct; 17(10):22. PubMed ID: 22031648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians.
    Halpern AC; Hanson LJ
    Int J Dermatol; 2004 Sep; 43(9):638-42. PubMed ID: 15357741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oculocutaneous albinism in sub-Saharan Africa: adverse sun-associated health effects and photoprotection.
    Wright CY; Norval M; Hertle RW
    Photochem Photobiol; 2015; 91(1):27-32. PubMed ID: 25298350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
    Zaravinos A; Kanellou P; Spandidos DA
    Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oculocutaneous albinism in a rural community of South Africa: a population genetic study.
    Lund PM; Maluleke TG; Gaigher I; Gaigher MJ
    Ann Hum Biol; 2007; 34(4):493-7. PubMed ID: 17620156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
    Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oculocutaneous albinism type 1A: a case report.
    Karaman A
    Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of MC1R variants in Indian oculocutaneous albinism patients: highlighting the risk of skin cancer among albinos.
    Sengupta M; Sarkar D; Mondal M; Samanta S; Sil A; Ray K
    J Genet; 2013; 92(2):305-8. PubMed ID: 23970088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.